Goldman Sachs’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Goldman Sachs’s Portfolio BRLI Stock Details BRLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-30,000	Closed	-$896K	–	6926
2013 Q3	$896K	Buy	+30,000	New	+$834K	﹤0.01%	4690

Other funds holding BRLI

SAM

Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

Goldman Sachs's BRLI Position: Q3 2015 in Review

Goldman Sachs sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 53,662 shares — an estimated $2.21M sold.

Goldman Sachs first reported a position in BRLI in Q2 2013 and held it in 8 quarters. The position peaked at $2.21M in Q2 2015. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

Goldman Sachs reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
Goldman Sachs sold 53,662 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $2.21M.
Goldman Sachs first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 8 quarters.
Goldman Sachs's BIO-REFERENCE LABS INC-NEW- position peaked at $2.21M in Q2 2015.
1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on Goldman Sachs's 13F filing for Q3 2015, filed 13 Nov 2015.